22-09-2026 17:17 via drugs.com

MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms

TUESDAY, Sept. 22, 2026-- Menopausal hormone therapy (MHT) initiation in perimenopausal or recently postmenopausal women with vasomotor symptoms may reduce cardiovascular disease (CVD) risk, with more pronounced benefits in women who initiated MHT...

High Intake of Eggs, Peanuts in Pregnancy Does Not Lower Allergy Risk

Gene Mutation Identified That Increases Lung Cancer Risk

Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years

Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis

Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL

Cirrhosis Can Recur After Liver Transplant

Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds

Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported

Intrauterine Instillation of Mepivacaine Reduces Pain of IUD Placement

Nighttime Light Exposure Linked to Sleep Parameters in Schizophrenia

Structured Exercise Should Be Considered as Adjunct Therapy for Cancer

Socioeconomic Status Linked to Mortality After Acute Hip Fracture Surgery

Oral Vitamin C Active in Clonal Cytopenia of Undetermined Significance

Altered Markers of Ovarian Development Seen With Fetal Acetaminophen Exposure

Desktop versie

MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms

Pharmaceutical Industry news